MARKET

SRGA

SRGA

RTI Surgical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.280
-0.020
-0.87%
After Hours: 2.300 +0.02 +0.88% 17:21 03/05 EST
OPEN
2.390
PREV CLOSE
2.300
HIGH
2.390
LOW
2.020
VOLUME
1.76M
TURNOVER
--
52 WEEK HIGH
3.970
52 WEEK LOW
1.460
MARKET CAP
243.23M
P/E (TTM)
-0.6205
1D
5D
1M
3M
1Y
5Y
Surgalign Holdings, Inc. Announces Date Change for Fourth Quarter and Full Year 2020 Earnings Release and Conference Call
Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on advancing spine surgery and improving patient outcomes, including through the application of digital technology, today announced that it is changing its earnings releas...
GlobeNewswire · 2d ago
Surgalign Holdings Schedules Fourth Quarter and Full Year 2020 Earnings Call for March 11, 2021
DEERFIELD, Ill., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on advancing spine surgery and improving patient outcomes, including through the application of digital technology, toda...
GlobeNewswire · 02/25 21:05
New Penny Stocks For Your February 2021 Watch List
Feb 24, 2021 (Penny Stocks via COMTEX) -- 4 Penny Stocks To Watch For February 2021 I'm not going to lie; we talk about penny stocks a lot. If you're among...
Penny Stocks · 02/24 21:10
Surgalign Holdings, Inc. Announces Record Date and Annual Meeting Date
DEERFIELD, Ill., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global surgical implant company (the “Company”), today announced that its 2021 Annual Meeting of Stockholders (the “Annual Meeting”) will be held virtually on May...
GlobeNewswire · 02/12 21:05
TLRY, GWPH, SSL and DGNR among premarket gainers
SELLAS Life Sciences (SLS) +60%.Tyme Technologies (TYME) +57% as the company granted U.S. patent claims covering use of TYME-19.10X Capital Venture Acquisition (VCVCU) +48% on plans to take Israeli electric-vehicle technology company REE Automotive
Seekingalpha · 02/03 13:31
--Analyst Actions: BTIG Starts Surgalign Holdings at Buy with $4 Price Target
MT Newswires · 02/03 13:14
BTIG Thinks Surgalign Holdings’ Stock is Going to Recover
BTIG analyst Ryan Zimmerman initiated coverage with a Buy rating on Surgalign Holdings (SRGA) today and set a price target of $4.00. The company's shares
SmarterAnalyst · 02/03 11:38
ARAY, GOOG, TENB and RDUS among after-hours movers
Gainers: [[ISBC]] +13.2%. [[RDUS]] +8.6%. [[SRGA]] +8.5%. [[ARAY]] +8.3%. [[GOOG]] +7.8%.Losers: [[TENB]] -10.6%. [[VYGR]] -6.3%. [[TLSA]] -5.3%. [[EVLO]] -4.6%. [[RAIL]] -4.5%.
Seekingalpha · 02/02 22:54
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SRGA. Analyze the recent business situations of RTI Surgical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SRGA stock price target is 5.00 with a high estimate of 8.00 and a low estimate of 4.000.
EPS
Institutional Holdings
Institutions: 166
Institutional Holdings: 47.14M
% Owned: 44.19%
Shares Outstanding: 106.68M
TypeInstitutionsShares
Increased
24
1.81M
New
29
874.99K
Decreased
29
1.58M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+2.73%
Healthcare Equipment & Supplies
+2.13%
Key Executives
President/Chief Executive Officer/Director
Michael Nefkens
Chairman/Director
Stuart Simpson
President/Chief Executive Officer/Director
Terry Rich
Chief Financial Officer/Chief Operating Officer
Jonathon Singer
Executive Vice President
Bryan Cornwall
Executive Vice President
Roger Rose
Executive Vice President
John Varela
Vice President - Finance/Controller
Ryan Bartolucci
Secretary
Thomas Rose
Vice President
Olivier Visa
Other
Scott Durall
Lead Director/Independent Director
Mark Stolper
Director
Brian Kushner
Director
Pawel Lewicki
Independent Director
Jeffrey Lightcap
Independent Director
Thomas McEachin
Independent Director
Philip Chapman
Independent Director
Paul Thomas
Independent Director
Adrian Smith
Independent Director
Nicholas Valeriani
Independent Director
Shirley Weis
No Data
About SRGA
RTI Surgical Holdings, Inc. is a surgical implant company. The Company designs, develops, manufactures and distributes biologic, metal and synthetic implants. The Company's implants are used in orthopedic, spine, sports medicine, plastic surgery, trauma and other surgical procedures to repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes. It operates in one reportable segment composed of lines of business, including spine, sports and international. The Company manufactures metal and synthetic implants and processes donated human musculoskeletal and other tissue and bovine and porcine animal tissue in producing allograft and xenograft implants using its BIOCLEANSE, TUTOPLAST and CANCELLE SP sterilization processes. The Company's implants are distributed directly to hospitals throughout the United States and in over 50 countries worldwide. It also owns augmented reality and artificial intelligence (ARAI) digital surgery platform.

Webull offers kinds of Surgalign Holdings Inc stock information, including NASDAQ:SRGA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRGA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SRGA stock methods without spending real money on the virtual paper trading platform.